|
|
Volumn 9, Issue 6, 1996, Pages 527-534
|
|
The three fates of immunosuppression in the next millenium: Selectivity, synergy, and specificity
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTISENSE OLIGONUCLEOTIDE;
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
MIZORIBINE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
RAPAMYCIN;
TACROLIMUS;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
APOPTOSIS;
DRUG POTENTIATION;
DRUG SELECTIVITY;
EDITORIAL;
GRAFT REJECTION;
HUMAN;
HUMAN CELL;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY GRAFT;
NONHUMAN;
PRIORITY JOURNAL;
T LYMPHOCYTE;
ANIMALS;
HUMANS;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
|
|
EID: 0029955930
PISSN: 09340874
EISSN: None
Source Type: Journal
DOI: 10.1007/BF00335550 Document Type: Editorial |
|
Times cited : (12)
|
|
References (0)
|
